Inland Empire Clinical Trials

Rialto, California 92377

1 studies enrolling now · 8 studies all time

What they study most

Cirrhosis, Hepatic Cirrhosis, Hepatic Encephalopathy (HE), Hepatic Impairment, Hepatitis B, Hepatocellular Cancer, Hepatocellular Carcinoma, Hypertension, Liver Cancer, Nonalcoholic Steatohepatitis, Nonalcoholic Steatohepatitis (NASH), Renal Impairment

Studies at this site

• Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434 — Recruiting now
• GT-032 Belapectin Hepatic Impairment — Completed
• A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension — Completed
• Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Completed
• ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk — Running, not enrolling
• A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics and Safety of VIR-2218 — Completed
• Phase 1 PK Study to Evaluate the PK of CIN-107 in Subjects With Hepatic Impairment — Completed
• MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy) — Completed